315 related articles for article (PubMed ID: 29309859)
41. Extraction, fractionation and re-fractionation of Artemisia nilagirica for anticancer activity and HPLC-ESI-QTOF-MS/MS determination.
Sahu N; Meena S; Shukla V; Chaturvedi P; Kumar B; Datta D; Arya KR
J Ethnopharmacol; 2018 Mar; 213():72-80. PubMed ID: 29109061
[TBL] [Abstract][Full Text] [Related]
42. Cytotoxicity of 4-hydroxy-N-(naphthalen-1-yl)-2-oxo-2H-chromene-3-carboxamide in multidrug-resistant cancer cells through activation of PERK/eIF2α/ATF4 pathway.
Lu X; Yan G; Klauck SM; Fleischer E; Klinger A; Sugimoto Y; Shan L; Efferth T
Biochem Pharmacol; 2021 Nov; 193():114788. PubMed ID: 34582772
[TBL] [Abstract][Full Text] [Related]
43. In vitro and in vivo evaluation of WK-X-34, a novel inhibitor of P-glycoprotein and BCRP, using radio imaging techniques.
Jekerle V; Klinkhammer W; Scollard DA; Breitbach K; Reilly RM; Piquette-Miller M; Wiese M
Int J Cancer; 2006 Jul; 119(2):414-22. PubMed ID: 16646006
[TBL] [Abstract][Full Text] [Related]
44. Cytotoxicity of compounds from Xylopia aethiopica towards multi-factorial drug-resistant cancer cells.
Kuete V; Sandjo LP; Mbaveng AT; Zeino M; Efferth T
Phytomedicine; 2015 Dec; 22(14):1247-54. PubMed ID: 26655407
[TBL] [Abstract][Full Text] [Related]
45. Putative molecular determinants mediating sensitivity or resistance towards carnosic acid tumor cell responses.
Mahmoud N; Saeed MEM; Sugimoto Y; Klinger A; Fleischer E; Efferth T
Phytomedicine; 2020 Oct; 77():153271. PubMed ID: 32659679
[TBL] [Abstract][Full Text] [Related]
46. Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis.
Green E; Samie A; Obi CL; Bessong PO; Ndip RN
J Ethnopharmacol; 2010 Jul; 130(1):151-7. PubMed ID: 20447452
[TBL] [Abstract][Full Text] [Related]
47. Pediatric glioblastoma cell line shows different patterns of expression of transmembrane ABC transporters after in vitro exposure to vinblastine.
Valera ET; de Freitas Cortez MA; de Paula Queiroz RG; de Oliveira FM; Brassesco MS; Jabado N; Faury D; Bobola MS; Machado HR; Scrideli CA; Tone LG
Childs Nerv Syst; 2009 Jan; 25(1):39-45. PubMed ID: 18946672
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of ALDH1A1 activity decreases expression of drug transporters and reduces chemotherapy resistance in ovarian cancer cell lines.
Januchowski R; Wojtowicz K; Sterzyſska K; Sosiſska P; Andrzejewska M; Zawierucha P; Nowicki M; Zabel M
Int J Biochem Cell Biol; 2016 Sep; 78():248-259. PubMed ID: 27443528
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxicity and modes of action of 4'-hydroxy-2',6'-dimethoxychalcone and other flavonoids toward drug-sensitive and multidrug-resistant cancer cell lines.
Kuete V; Nkuete AH; Mbaveng AT; Wiench B; Wabo HK; Tane P; Efferth T
Phytomedicine; 2014 Oct; 21(12):1651-7. PubMed ID: 25442273
[TBL] [Abstract][Full Text] [Related]
50. Modulation of P-glycoprotein but not MRP1- or BCRP-mediated drug resistance by LY335979.
Shepard RL; Cao J; Starling JJ; Dantzig AH
Int J Cancer; 2003 Jan; 103(1):121-5. PubMed ID: 12455064
[TBL] [Abstract][Full Text] [Related]
51. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
52. Reversal of P-gp and BCRP-mediated MDR by tariquidar derivatives.
Li XQ; Wang L; Lei Y; Hu T; Zhang FL; Cho CH; To KK
Eur J Med Chem; 2015 Aug; 101():560-72. PubMed ID: 26197160
[TBL] [Abstract][Full Text] [Related]
53. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.
Katayama K; Masuyama K; Yoshioka S; Hasegawa H; Mitsuhashi J; Sugimoto Y
Cancer Chemother Pharmacol; 2007 Nov; 60(6):789-97. PubMed ID: 17345086
[TBL] [Abstract][Full Text] [Related]
54. Phytochemical analysis and cytotoxicity towards multidrug-resistant leukemia cells of essential oils derived from Lebanese medicinal plants.
Saab AM; Guerrini A; Sacchetti G; Maietti S; Zeino M; Arend J; Gambari R; Bernardi F; Efferth T
Planta Med; 2012 Dec; 78(18):1927-31. PubMed ID: 23154840
[TBL] [Abstract][Full Text] [Related]
55. Ethnobotanical survey and cytotoxicity testing of plants of South-western Nigeria used to treat cancer, with isolation of cytotoxic constituents from Cajanus cajan Millsp. leaves.
Ashidi JS; Houghton PJ; Hylands PJ; Efferth T
J Ethnopharmacol; 2010 Mar; 128(2):501-12. PubMed ID: 20064598
[TBL] [Abstract][Full Text] [Related]
56. Cytotoxicity of a naturally occurring furoquinoline alkaloid and four acridone alkaloids towards multi-factorial drug-resistant cancer cells.
Kuete V; Fouotsa H; Mbaveng AT; Wiench B; Nkengfack AE; Efferth T
Phytomedicine; 2015 Sep; 22(10):946-51. PubMed ID: 26321744
[TBL] [Abstract][Full Text] [Related]
57. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
[TBL] [Abstract][Full Text] [Related]
58. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
59. Cytotoxicity of two naturally occurring flavonoids (dorsmanin F and poinsettifolin B) towards multi-factorial drug-resistant cancer cells.
Kuete V; Mbaveng AT; Zeino M; Ngameni B; Kapche GD; Kouam SF; Ngadjui BT; Efferth T
Phytomedicine; 2015 Jul; 22(7-8):737-43. PubMed ID: 26141760
[TBL] [Abstract][Full Text] [Related]
60. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
